Last $1.24 USD
Change Today -0.02 / -1.59%
Volume 99.8K
ARQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Loberg Ph.D.

Director, Member of Science Committee and Member of Compensation, Nominating & Governance Committee, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 5 different industries.

See Board Relationships
66$86,150

Background*

Dr. Michael D. Loberg, PhD served as an Acting Chief Executive Officer and Acting President of Inotek Pharmaceuticals Corporation from April 2008 to October 1, 2008. Dr. Loberg served as Chief Executive Officer of NitroMed Inc. from September 1997 to March 21, 2006 and also as its President from September 2003 to March 21, 2006. Dr. Loberg's career spans more than 25 years in the pharmaceutical industry, including almost 12 years of direct involvement in drug discovery ...

Read Full Background

Corporate Headquarters*

19 Presidential Way
Woburn, Massachusetts 01801

United States

Phone: 781-994-0300
Fax: 781-376-6019

Board Members Memberships*

1997-2006
Former Chief Executive Officer, President and Director
1997-2009
Former Director and Member of Audit Committee
2004-Present
Director
2005-N/A
Former Chairman
2007-Present
Director, Member of Science Committee and Member of Compensation, Nominating & Governance Committee

Education*

PhD
Washington University, St. Louis
BS
Trinity College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$57,750
Total Calculated Compensation$86,150
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARQL:US $1.24 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Tuan Ha-Ngoc Chief Executive Officer, President and Director
AVEO Pharmaceuticals, Inc.
$567.9K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.